EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Relapse following withdrawal of D‐penicillamine from combination (D‐penicillamine + zinc) therapy in hepatic Wilson disease

Kalpana Panda iD, Bikrant B Lal iD, Vikrant Sood iD, Rajeev Khanna iD, Seema Alam iD

Journal of Pediatric Gastroenterology and Nutrition · 2024

DOI: 10.1002/jpn3.12128 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Kalpana Panda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Hepatolenticular Degeneration, Penicillamine, Recurrence, Drug Therapy, Combination. Die Arbeit nennt 34 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Long‐term D‐penicillamine (D‐pen) therapy in Wilson disease (WD) has numerous adverse effects which advocates its withdrawal, but with an inherent risk of relapse. This prospective observational study was conducted with the objective of evaluating incidence of relapse following withdrawal of D‐pen from combination (D‐pen + zinc) therapy in maintenance phase of previously symptomatic hepatic WD.

Methods

Hepatic WD patients 2 years with 6 months of biochemical remission were included. Biochemical remission was defined as achievement of (i) aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤1.5 times upper limit of normal (ULN), (ii) serum albumin >3.5 g/dL, international normalized ratio (INR)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatolenticular DegenerationPenicillamineRecurrenceDrug Therapy, CombinationChelating AgentsHumansFemaleMaleProspective StudiesAdolescentChildAlanine TransaminaseAspartate AminotransferasesZincLiver Function TestsCopperWithholding Treatment

Stichwörter der Autor:innen

D‐pencillamineWilson diseasechildrenrelapsezinc

Substanzen

PenicillamineChelating AgentsAlanine TransaminaseAspartate AminotransferasesZincCopper

Autor:innen und Institutionen

  • Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

ORCID-Profile: Kalpana Panda, Bikrant B Lal, Vikrant Sood, Rajeev Khanna, Seema Alam

Förderung

  • None

Zitieren

APA

Panda, K., Lal, B. B., Sood, V., Khanna, R., & Alam, S. (2024). Relapse following withdrawal of D‐penicillamine from combination (D‐penicillamine + zinc) therapy in hepatic Wilson disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12128

Vancouver

Panda K, Lal BB, Sood V, Khanna R, Alam S. Relapse following withdrawal of D‐penicillamine from combination (D‐penicillamine + zinc) therapy in hepatic Wilson disease. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12128

BibTeX
@article{Panda2024,
  author = {Panda, Kalpana and Lal, Bikrant B and Sood, Vikrant and Khanna, Rajeev and Alam, Seema},
  title = {Relapse following withdrawal of D‐penicillamine from combination (D‐penicillamine + zinc) therapy in hepatic Wilson disease},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  doi = {10.1002/jpn3.12128}
}
Kostenlos starten →